Docetaxel Injection and Thalidomide: Interaction Details
- Docetaxel Injection
- TaxotereDocefrezDocivyx +1 more
- Thalidomide
- Thalomid
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS
Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
- Dr. Brian Staiger, PharmD, BCPS, is a clinical pharmacist and pharmacotherapy specialist.
- AI-assisted, written
- AI is used only to summarize verified clinical information, never the open internet.
- Editorial policy
- How we build our interaction pages →
- Our AI policy →
A close look at the Docetaxel Injection and Thalidomide interaction:
Docetaxel Injection
- Taxotere
- Docefrez
- Docivyx
- Beizray
What Happens When You Take Docetaxel Injection With Thalidomide
What can happen when they are taken together (rated Major)
An increased risk of venous thromboembolism
Interaction Deep Dive
A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →
When thalidomide is combined with docetaxel for prostate cancer, the rate of venous thromboembolism rises markedly. Caution is warranted for clinicians who prescribe these two drugs together.1
The Docetaxel Injection and Thalidomide Interaction, Explained
Docetaxel is a chemotherapy medicine, and thalidomide is often used to treat certain cancers. Studies in prostate cancer found that when the two are used together, blood clots in the veins (called venous thromboembolism, or VTE) happen more often than with either one alone. Researchers don't know exactly why this happens.
Clots can show up as leg pain, swelling, warmth, or redness, or as shortness of breath or chest pain. Please don't stop or change either medicine on your own. Your care team knows this risk and can watch for early signs. Tell your doctor or pharmacist right away if you notice any of these symptoms.
Interaction: Adding thalidomide to docetaxel (studied in prostate cancer) significantly increases the incidence of venous thromboembolism. Both agents are independently associated with thrombotic risk, but the mechanism of the combined effect is unknown.
- Onset: delayed
- Evidence: established
- Severity: major
- Management: monitor for signs and symptoms of VTE (leg pain, swelling, warmth, erythema, dyspnea, chest pain). Use caution with ; thromboprophylaxis decisions should be individualized by the treating team.
See the 1 reference behind this explanation ↓
From the HelloPharmacist Pharmacy Team
AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .
How we build these pages · How we use AI · Our editorial policy
Why Docetaxel Injection and Thalidomide Interact
The likely mechanism
Unknown
“Unknown” here means the studies and labels behind this record do not say how the interaction happens. It does not mean the interaction is unlikely.
How to Manage the Docetaxel Injection and Thalidomide Interaction
Your care team can manage this by watching closely for clot symptoms while you take both medicines.
- Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
- Know the warning signs: ongoing leg pain, leg swelling, warmth or redness, shortness of breath, or chest pain.
- Report any of these to your doctor or pharmacist right away. Chest pain or sudden breathlessness needs urgent medical care.
- Your team may monitor you more closely during treatment.
Management is individual — confirm any change with your pharmacist or prescriber.
Questions for Your Pharmacist
- Does my dose of Docetaxel Injection or Thalidomide need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there another option that avoids this interaction?
Literature Reports
1 report from the published literature. Each one is headed by the title of the published study it comes from.
What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.
-
Report 1 · Study title
Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer
Adding thalidomide to docetaxel for prostate cancer was associated with a significantly higher frequency of venous thromboembolism (VTE) than the VTE incidence seen with docetaxel alone. A randomized phase II study designed to assess the frequency of VTE in this setting enrolled seventy male patients with advanced androgen-independent prostate cancer.
Each patient was assigned to one of two regimens: intravenous docetaxel 30 mg/m2/week for 3 consecutive weeks followed by 1 week off (n equal to 23), or continuous oral thalidomide 200 mg every evening combined with the same docetaxel schedule (n equal to 47). The 4-week cycle was repeated until excessive toxicity (grade 3 or higher) or disease progression was evident.
No patient among the 23 in the docetaxel-only group developed clinically evident VTE, although none of them had a prior history of VTE. In the combination group, nine patients developed VTE, and six of these were first-time VTE events.
Analysis of all patients with the Fisher exact test, irrespective of VTE history, showed a significantly greater VTE frequency in those receiving both drugs (19%) than in those receiving docetaxel alone (0%) (p equal 0.025). The difference was no longer significant (p=0.06) once the 3 men with recurrent VTE were excluded from the analysis. Clinicians should use caution when adding thalidomide to chemotherapeutic regimens.1
Docetaxel Injection and Thalidomide: Common Questions
How serious is the Docetaxel Injection and Thalidomide interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How is the Docetaxel Injection and Thalidomide interaction managed?
Your care team can manage this by watching closely for clot symptoms while you take both medicines. Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Know the warning signs: ongoing leg pain, leg swelling, warmth or redness, shortness of breath, or chest pain. Report any of these to your doctor or pharmacist right away. Chest pain or sudden breathlessness needs u… Management is individual — always follow your own care team's guidance.
How quickly could this interaction happen?
The documented onset is "delayed". Effects tend to build up gradually over days to weeks.
How strong is the evidence for this interaction?
The evidence is graded "established". Well documented — supported by controlled studies or strong clinical data.
Ask About the Docetaxel Injection and Thalidomide Interaction
Ask in your own words about taking Docetaxel Injection and Thalidomide together. The answer comes from this page’s interaction record and both drugs’ own information.
This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.
AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.
References (1)
- Horne III MK, Figg WD, Arlen P, et al: Increased frequency of venous thromboembolism with the combination of docetaxel and thalidomide in patients with metastatic androgen-independent prostate cancer. Pharmacotherapy 2003; 23(3):315-318. PubMed
Other Serious Interactions of Docetaxel Injection and Thalidomide
Also serious with Docetaxel Injection
Also serious with Thalidomide
These Medications Also Interact With Supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
With Thalidomide
- Activated CharcoalMajor
- SeleniumModerate
- AshwagandhaModerate
- MelatoninModerate
- RhodiolaModerate
- EleutheroModerate
- EchinaceaModerate
- Blue-green AlgaeModerate
- + 62 more
Check everything you take with our drug–supplement interaction checker.
Still Have Questions About This Combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
About This Library
Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →
What Each Rating Means
Severity Levels
- Contraindicated These should generally not be used together.
- Major Potentially serious — often needs a change or close monitoring. This interaction.
- Moderate Can be significant — usually manageable with monitoring.
- Minor Usually limited clinical impact.
Evidence Grades
- EstablishedWell documented — supported by controlled studies or strong clinical data. This interaction.
- ProbableGood supporting evidence, though not definitively proven.
- SuspectedSome evidence suggests this interaction, but it is not well established.
- PossibleLimited or conflicting evidence; the interaction may occur.
- TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.
How Soon It Shows
- RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
- DelayedEffects tend to build up gradually over days to weeks. This interaction.
- UnspecifiedThe timing of this interaction is not well characterized.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.